| Phase 4 |
| NCT07094893 |
Anti-EGFR Agents in Patients With Right-sided Advanced Colorectal Cancer With Wild-type… |
Colorectal Cancer |
Not Yet Recruiting |
| Phase 3 |
| NCT06897644 |
Gemcitabine Plus Nab-paclitaxel as Switch Maintenance Versus Continuation of Modified… |
Pancreatic Adenocarcinoma Advanced or Metastatic |
Recruiting |
| NCT06733038 |
FOLFOXIRI Plus Bevacizumab With or Without Atezolizumab as 1st Line Treatment of pMMR and… |
Colorectal Cancer |
Recruiting |
| NCT07763171 |
Paclitaxel, Ramucirumab and Tislelizumab Switch Maintenance in Advanced HER2-negative and… |
Gastroesophageal Adenocarcinoma |
Not Yet Recruiting |
| Phase 2/3 |
| NCT06037980 |
CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative Chemotherapy Versus… |
Biliary Tract Cancer |
Recruiting |
| Phase 2 |
| NCT04681469 |
Induction and Maintenance Treatment With PARP Inhibitor and Immunotherapy in HPV-negative… |
Head and Neck Squamous Cell Carcinoma |
Recruiting |
| NCT06253650 |
Adjuvant TRastuzumab Deruxtecan for HER2-positive Gastroesophageal Cancer With… |
Gastric Cancer |
Recruiting |
| NCT06869473 |
Cetuximab Plus Platinum and Taxane-based Chemotherapy, Followed by Avelumab and… |
Head and Neck Squamous Cell Carcinoma (HNSCC) |
Recruiting |
| NCT07407465 |
Upfront Trastuzumab-Deruxtecan Plus Capecitabine and Bevacizumab for Patients With HER-2… |
Colorectal Cancer |
Recruiting |
| NCT05845450 |
Pre-operative Targeted Treatments in Molecularly Selected Resectable Colorectal Cancer… |
Colorectal Cancer |
Recruiting |
| NCT07485296 |
Effect of Postbiotics on Microbiota and Systemic Immunomodulation of Pembrolizumab as… |
Head & Neck Squamous Cell Carcinoma |
Recruiting |
| NCT04817826 |
TremelImumab aNd Durvalumab For the Non-operatIve Management (NOM) of MSI-high Resectable… |
Gastric Cancer |
Active, Not Recruiting |
| NCT06578559 |
Phase II Study of ctDNA-guided Encorafenib Plus Cetuximab Retreatment in Patients BRAF… |
Colorectal Cancer |
Active, Not Recruiting |
| NCT05594290 |
Chemo-immunotherapy in Patients With Resectable Merkel Cell Carcinoma Prior to Surgery |
Merkel Cell Carcinoma |
Active, Not Recruiting |
| NCT04787341 |
PAnitumumab REchallenge Followed by REgorafenib Versus the Reverse Sequence |
Colorectal Cancer |
Active, Not Recruiting |
| NCT04806646 |
Tailored Sonidegib Schedule After Complete Response in BCC |
Locally Advanced Basal Cell Carcinoma |
Active, Not Recruiting |
| NCT04825990 |
Pembrolizumab and Olaparib in Recurrent/Metastatic, Platinum Resistant Nasopharyngeal… |
Nasopharyngeal Carcinoma |
Active, Not Recruiting |
| NCT05253846 |
Short-course Radiotherapy Followed by Consolidation Chemotherapy. 2021-001206-29 |
Locally Advanced Rectal Cancer |
Active, Not Recruiting |
| Phase 1/2 |
| NCT04564898 |
Trifluridine/Tipiracil in Combination With Capecitabine and Bevacizumab in Metastatic… |
Colorectal Cancer Metastatic |
Active, Not Recruiting |